|
Name |
1-Methoxy-4-methylbenzene
|
Molecular Formula | C8H10O | |
IUPAC Name* |
1-methoxy-4-methylbenzene
|
|
SMILES |
CC1=CC=C(C=C1)OC
|
|
InChI |
InChI=1S/C8H10O/c1-7-3-5-8(9-2)6-4-7/h3-6H,1-2H3
|
|
InChIKey |
CHLICZRVGGXEOD-UHFFFAOYSA-N
|
|
Synonyms |
4-Methylanisole; 1-METHOXY-4-METHYLBENZENE; 104-93-8; 4-Methoxytoluene; p-Methylanisole; p-Methoxytoluene; Benzene, 1-methoxy-4-methyl-; p-methyl anisole; p-Cresol methyl ether; p-Cresyl methyl ether; Anisole, p-methyl-; 4-Methyl anisole; Methyl p-cresol; Methyl p-tolyl ether; p-Tolyl methyl ether; Methyl p-cresyl ether; 1-Methyl-4-methoxybenzene; 4-Methyl-1-methoxybenzene; 4-Methylphenol methyl ether; Methyl 4-methylphenyl ether; para-Methylanisole; Methyl-para-cresol; para-Methoxytoluene; Methyl p-methylphenyl ether; p-methylanisol; 4-methylanisol; para-Cresyl methyl ether; para-methyl anisole; 1-Methoxy-4-methyl-benzene; FEMA No. 2681; 4-Methylanizole; NSC 6254; para-Methyl anisol; 4-methylmethoxybenzene; 10FAI0OR9W; CHEMBL154155; CHEBI:89728; NSC-6254; Toluene, 4-methoxy-; FEMA Number 2681; PARA-CRESOL DEUTEROMETHYL ETHER; HSDB 5363; EINECS 203-253-7; UNII-10FAI0OR9W; AI3-07621; p- methylanisole; p-Methyl-Anisole; p-Methoxy toluene; 4-methoxy-toluene; MFCD00008413; VANADIUMGALLIDE; P- METHOXYTOLUENE; 4-Methylanisole, 99%; DSSTox_CID_6710; 1-methyoxy-4-methylbenzene; EC 203-253-7; DSSTox_RID_78191; DSSTox_GSID_26710; SCHEMBL12464; 4-CRESOL METHYL ETHER; WLN: 1OR D1; P-METHYLANISOLE [FHFI]; SCHEMBL2489775; P-METHYL ANISOLE [FCC]; PARA-CRESOL METHYL ETHER; DTXSID9026710; SCHEMBL12015216; cresyl methyl ether, methylanisol; FEMA 2681; AMY5180; NSC6254; ZINC1693359; 4-Methylanisole, analytical standard; Tox21_201081; BDBM50008555; STL268886; AKOS000121016; 4-Methylanisole, >=99%, FCC, FG; CS-W013551; HY-W012835; NCGC00248917-01; NCGC00258634-01; 1-METHOXY-4-METHYLBENZENE [HSDB]; BS-23266; CAS-104-93-8; FT-0618970; M0149; EN300-16112; W-108799; Q15726084; Z53834227; F0001-0094
|
|
CAS | 104-93-8 | |
PubChem CID | 7731 | |
ChEMBL ID | CHEMBL154155 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 122.16 | ALogp: | 2.7 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 9.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.556 |
Caco-2 Permeability: | -4.287 | MDCK Permeability: | 0.00002320 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.116 |
30% Bioavailability (F30%): | 0.335 |
Blood-Brain-Barrier Penetration (BBB): | 0.885 | Plasma Protein Binding (PPB): | 87.22% |
Volume Distribution (VD): | 2.234 | Fu: | 9.73% |
CYP1A2-inhibitor: | 0.964 | CYP1A2-substrate: | 0.958 |
CYP2C19-inhibitor: | 0.914 | CYP2C19-substrate: | 0.878 |
CYP2C9-inhibitor: | 0.349 | CYP2C9-substrate: | 0.869 |
CYP2D6-inhibitor: | 0.374 | CYP2D6-substrate: | 0.92 |
CYP3A4-inhibitor: | 0.142 | CYP3A4-substrate: | 0.525 |
Clearance (CL): | 11.149 | Half-life (T1/2): | 0.677 |
hERG Blockers: | 0.088 | Human Hepatotoxicity (H-HT): | 0.09 |
Drug-inuced Liver Injury (DILI): | 0.265 | AMES Toxicity: | 0.104 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.634 | Carcinogencity: | 0.674 |
Eye Corrosion: | 0.975 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.105 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000318 | 0.613 | D02DPU | 0.373 | ||||
ENC000201 | 0.571 | D0DJ1B | 0.333 | ||||
ENC000233 | 0.567 | D0P1UX | 0.328 | ||||
ENC000223 | 0.559 | D05CKR | 0.327 | ||||
ENC001460 | 0.556 | D09WKB | 0.317 | ||||
ENC000298 | 0.526 | D0J5DC | 0.308 | ||||
ENC000086 | 0.516 | D09GYT | 0.300 | ||||
ENC000310 | 0.514 | D08JZS | 0.299 | ||||
ENC000199 | 0.486 | D06OIV | 0.298 | ||||
ENC000638 | 0.475 | D0X0WU | 0.288 |